Gilead Lift

Gilead and Lift partnership logo

Cell therapy is a cutting-edge cancer treatment that builds upon decades of progress in immunotherapies by modifying a patient's own immune cells to target cancer cells. As this emerging treatment advances, our approach to improving education and awareness must evolve as well.

The Gilead Lift program is accepting requests from organizations in the U.S. that aim to improve the experience and education of patients, families and caregivers exploring cell therapies. The program also supports organizations committed to increasing awareness, education and access to clinical trials.

Outreach and Education

Gilead seeks to support programs that improve engagement and educate patients, families and caregivers about cell therapy. This includes helping patients and families understand and navigate their treatment journey, developing tools to enhance communication between patients and providers, and enhancing post-therapy planning and support.

The Role of Clinical Trials

Gilead is seeking proposals that demonstrate how clinical trials advance research and improve outcomes for people with cancer. These include innovative approaches to raise awareness about clinical trials, increase access and participation in trials, and enhance communication between patients and providers.

Kite Named to MIT Technology Review's 50 Smartest Companies

Last year, Kite (a Gilead Company) was named to MIT Technology Review's list of 50 Smartest Companies. Kite was selected for its technological leadership and business acumen in the field of CAR T cell therapy, which refers to a therapy that uses transformed cells to treat cancer.

Read more about Kite